Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Endeavour Vision Highlights Humanity Of Medtech, Invests In Unmet Needs

Executive Summary

Unmet needs are at the core of Endeavour Vision’s investment strategy, accepting that payment models may need to change as patients become more directly involved in device development.

You may also be interested in...



Digital Health Start-Ups Continue To Be Attractive SPAC Targets

According to Rock Health, 52 health-care focused SPACs are looking for targets. This comes as blank check companies are facing rising scrutiny by regulators.

New Training Methods Could Reduce Bias In Artificial Intelligence

A “federated” training method could be used to reduce bias in AI, according to one expert on patient safety.

Exec Chat: Cumulus Neuroscience Help Trials Collect Previously Underutilized, Vital Data

Cumulus Neuroscience, previously known as BrainWaveBank, announced a £6m financing round to help develop its unique neurological data collection system.

Topics

Related Companies

UsernamePublicRestriction

Register

MT143827

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel